Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 24 Breast Neoplasms 15 Sarcoma 9 Myelodysplastic Syndromes 9 Carcinoma, Non-Small-Cell Lung 9 Stomach Neoplasms 8 Multiple Myeloma 7 Leukemia, Myelomonocytic, Chronic 7 Myeloproliferative Disorders 6 Uterine Cervical Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Prostatic Neoplasms 4 Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Leukemia, Monocytic, Acute 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Advanced Solid Tumour 4 Stomatitis 3 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Mucositis 3 Leukemia, Myelomonocytic, Acute 3 Esophageal Squamous Cell Carcinoma 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3

Interventions

Methylprednisolone 2 fish oil triglycerides 1 Prednisone 1 Methylprednisolone Hemisuccinate 1 Injections 1 Infliximab 1 Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colitis × Injections × Clear all

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡